Human papillomavirus infection and cervical cancer: epidemiology, screening, and vaccination—review of current perspectives

CK Chan, G Aimagambetova, T Ukybassova… - Journal of …, 2019 - Wiley Online Library
Viral infections contribute as a cause of 15–20% of all human cancers. Infection by
oncogenic viruses can promote different stages of carcinogenesis. Among many types of …

RETRACTED ARTICLE: Molecular mechanisms in progression of HPV-associated cervical carcinogenesis

SM Gupta, J Mania-Pramanik - Journal of biomedical science, 2019 - Springer
Cervical cancer is the fourth most frequent cancer in women worldwide and a major cause of
mortality in developing countries. Persistent infection with high-risk human papillomavirus …

Cervical cancer and its precursors: a preventative approach to screening, diagnosis, and management

SE Stumbar, M Stevens, Z Feld - Primary Care: Clinics …, 2019 - primarycare.theclinics.com
Cervical cancer affects the cells lining the cervix, most commonly occurring in the cells of the
transformation zone, which is the part of the cervix where the glandular cells of the …

Human papillomavirus infection in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of …

PV Chin‐Hong, GE Reid… - Clinical …, 2019 - Wiley Online Library
These guidelines from the American Society of Transplantation Infectious Diseases
Community of Practice update the epidemiology and management of human papillomavirus …

HPV genotype prevalence and distribution during 2009–2018 in Xinjiang, China: baseline surveys prior to mass HPV vaccination

J Wang, D Tang, K Wang, J Wang, Z Zhang, Y Chen… - BMC women's …, 2019 - Springer
Background The aim of this paper was to conduct a baseline survey of HPV infection in
unvaccinated women in Xinjiang Uyghur Autonomous Region before the mass use of HPV …

[HTML][HTML] Infection and vaccine-induced HPV-specific antibodies in cervicovaginal secretions. A review of the literature

J Pattyn, S Van Keer, W Tjalma, V Matheeussen… - Papillomavirus …, 2019 - Elsevier
Background Human papillomavirus (HPV) infects and propagates in the cervical mucosal
epithelium. Hence, in addition to assessing systemic immunity, the accurate measurement of …

The promise of combining cancer vaccine and checkpoint blockade for treating HPV-related cancer

T Shibata, BJ Lieblong, T Sasagawa… - Cancer treatment …, 2019 - Elsevier
Human papillomavirus (HPV)-associated intraepithelial neoplasia or cancers are ideal
candidates for cancer immunotherapy since HPV oncoproteins, such as E6 and E7 proteins …

[HTML][HTML] Detección y tipificación del Virus Papiloma Humano en el marco del tamizaje virológico para la detección de lesiones del cuello uterino en Asunción …

ML Bobadilla, V Villagra, ME Zorrilla… - Memorias del Instituto …, 2019 - scielo.iics.una.py
En Paraguay la incidencia de cáncer de cuello uterino (CCU) es superior a las observadas
en otros países de la región. El agente etiológico asociado al CCU es el virus papiloma …

Association of age and viral factors with high-risk HPV persistence: a retrospective follow-up study

W Li, Y Meng, Y Wang, X Cheng, C Wang, S Xiao… - Gynecologic …, 2019 - Elsevier
Abstract Objective Cervical HR-HPV persistence is the main risk factor for cervical cancer.
We aimed to investigate the association of age and viral factors with HR-HPV persistence …

Evaluation of TypeSeq, a novel high-throughput, low-cost, next-generation sequencing-based assay for detection of 51 human papillomavirus genotypes

S Wagner, D Roberson, J Boland… - The Journal of …, 2019 - academic.oup.com
Background Human papillomaviruses (HPV) cause over 500 000 cervical cancers each
year, most of which occur in low-resource settings. Human papillomavirus genotyping is …